Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

Transforming from a 6.5-inch phone to a 10-inch tablet, this device is a marvel of innovation. Yet, its high price and ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Samsung’s Galaxy Tab A11+ isn’t trying to out-iPad Apple with flashy extras. Instead, it focuses on the things that matter ...

Some of the best tablets launched in 2025 cater to a wide range of users, including students, professionals, creators, and ...

The pocket-friendly Samsung Galaxy Tab A11+ will be available in the US starting January 8 for $249.99.

Himax’s latest LCoS solution sets a new industry benchmark across multiple dimensions. With a resolution of 720 × 720, it delivers sharp and detailed images even in a compact microdisplay form factor.

With its impressive display, excellent performance, and all-day battery life, the Samsung Galaxy Tab A9+ is an ideal companion for everyday life as a multimedia and productivity tool. Now that it’s on ...

MEMS Speaker Market is expected to reach to US$ 13.4 Bn by 2035, Driven by Rising Demand for Smart Wearables and Hearables ...

As therapy for chronic lymphocytic leukemia (CLL) continues to evolve, 2025 brought research, regulatory news, and expert ...

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

Electrovaya shows strong revenue growth and a pivot to profitability but faces contradictions that warrant investor caution. Read more on ELVA stock here.